Related Experiment Videos
Deformation analysis to detect and quantify active lesions in three-dimensional medical image sequences
1FOCUS Imaging Les Genets, Valbonne, France.
IEEE Transactions on Medical Imaging
|July 23, 1999
Summary
This study introduces a novel volumetric analysis technique for precisely measuring lesion volume changes over time. The method accurately detects evolving lesions and quantifies volume variations without requiring precise lesion segmentation.
Area of Science:
- Medical imaging analysis
- Quantitative medical research
- Biomedical engineering
Background:
- Precise evaluation of temporal lesion volume variations is critical for pharmaceutical trials, treatment decisions, and patient monitoring.
- Existing methods often require detailed lesion segmentation, which can be challenging and time-consuming.
Purpose of the Study:
- To develop and validate a novel volumetric analysis technique for precise quantification of lesion volume changes.
- To enable automated detection and measurement of evolving lesions with minimal user input.
- To differentiate between tissue transformation and mass changes within lesions.
Main Methods:
- Combines rigid registration of 3-D medical images, nonrigid deformation computation, and flow-field analysis.
- Utilizes an approximate region of interest (ROI) designation, eliminating the need for precise lesion segmentation.
- Distinguishes tissue transformation (intensity changes) from expansion/contraction (mass changes).
Main Results:
- The technique successfully detects evolving lesions and quantitatively measures volume variations.
- Demonstrated effectiveness on synthesized volumetric image sequences.
- Applied to a real patient case of multiple sclerosis (MS) to quantify in vivo mass effect.
Conclusions:
- The developed technique offers a robust and efficient method for analyzing temporal lesion volume dynamics.
- Its ability to work with approximate ROIs makes it highly applicable in clinical settings and research.
- This approach advances the quantitative assessment of disease progression and treatment response in conditions like multiple sclerosis.